drugset / Trial / NCT07412288
First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants
RandomizedSequentialDouble-blindOther
Summary
This is a first-in-human study to evaluate safety and tolerability, pharmacokinetics, and pharmacodynamics of single and multiple dose levels of KT-579 in healthy male and female adult participants.
Timeline
- Start
- 2026-02-23
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | KT-579 | Unknown | — | Oral |
Indications
No indication recorded.